Vitiligo is included in medical insurance. It can be reimbursed through outpatient service or hospitalization, and the hospital will reimburse it according to the overall price. In the case of outpatient medical reimbursement, corresponding measures should be taken according to the symptoms of local municipal medical institutions. Patients with vitiligo should take corresponding treatment measures in time, and do a good job of prevention to avoid recurrence.

In some areas, vitiligo has been included in the category of reimbursement for chronic diseases. Insured patients with vitiligo can enjoy the reimbursement policy for chronic diseases outpatient service with the certificate of chronic diseases in time. Vitiligo is a common acquired localized or systemic skin depigmentation disease. It is caused by the disappearance of melanocyte function in skin, but its mechanism is not clear. It can occur in all parts of the body, usually around the back of fingers, wrists, forearms, face, neck and genitals.

The biggest harm of vitiligo is man-made harm. The symptom of vitiligo is leukoplakia, which seriously affects the external image of patients and greatly affects their study, employment, marriage and social interaction. Many people have certain discrimination against patients with vitiligo, which leads to a devastating blow to patients' self-esteem, which leads to a series of psychological diseases. Some patients commit suicide because of inferiority complex, which are the hazards of vitiligo.

Legal basis: Article 28 of the Social Insurance Law of People's Republic of China (PRC).

Medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency rescue shall be paid by the basic medical insurance fund in accordance with state regulations.